Scavenger receptors mediate adhesion of activated B lymphocytes

Exp Cell Res. 1998 Feb 25;239(1):16-22. doi: 10.1006/excr.1997.3876.

Abstract

The scavenger receptor (SR-A) is considered to play a role in host defense by scavenging endotoxins, oxidized proteins, and denatured or otherwise modified self components, which are routed toward degradation in macrophages. Recent data suggest that SR-A also functions as an adhesion molecule. Our previous finding of SR-A expression by high endothelial cells of venules and on follicular dendritic cells in peripheral lymph nodes prompted us to investigate whether SR-A can act as an addressin for lymphocytes. We describe here that activated B cells adhere to CHO cells transfected with either the type I or type II isoform of SR-A. In contrast, resting B cells isolated from peripheral blood did not adhere to SR-A transfected CHO cells. Other types of leukocytes did not bind to SR-A. The adhesive properties of B lymphocytes in different stages of activation were further explored using lymphoma cell lines of the B cell lineage. The in vitro EBV-transformed B cell line IARC171 showed enhanced adhesiveness to SR-A, whereas the Burkitt lymphoma cell lines, BL41, Rael, and Bl16 did not. The SR-A-dependent adhesion of B-lymphoblasts occurred both at 37 and 4 degrees C, suggesting that it was not dependent on cell metabolism. The known polyanionic ligands for SR-A, fucoidan, and acetylated low density lipoprotein, which bind to a positively charged portion of the collagen-like domain of SR-A, did not inhibit adhesion. This finding suggests that SR-A mediates adhesion of activated B lymphocytes through a binding site that differs from the one that binds polyanionic ligands. Together, our data suggest that SR-A plays a role in the recruitment of activated B cells into lymph nodes and inflammatory lesions by acting as an adhesion molecule for such cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticoagulants / pharmacology
  • B-Lymphocytes / cytology
  • B-Lymphocytes / immunology
  • B-Lymphocytes / physiology*
  • Burkitt Lymphoma
  • CHO Cells
  • Cell Adhesion / drug effects
  • Cell Adhesion / physiology*
  • Cell Line, Transformed
  • Cells, Cultured
  • Cricetinae
  • Flow Cytometry
  • Herpesvirus 4, Human / genetics
  • Humans
  • Interleukin-2 / pharmacology
  • Interleukin-4 / pharmacology
  • Ligands
  • Lipoproteins, LDL / blood
  • Lipoproteins, LDL / pharmacology
  • Lymphocyte Activation*
  • Membrane Proteins*
  • Monocytes / physiology
  • Polysaccharides / pharmacology
  • Receptors, Immunologic / biosynthesis
  • Receptors, Immunologic / physiology*
  • Receptors, Lipoprotein*
  • Receptors, Scavenger
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / pharmacology
  • Scavenger Receptors, Class A
  • Scavenger Receptors, Class B
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Anticoagulants
  • Interleukin-2
  • Ligands
  • Lipoproteins, LDL
  • Membrane Proteins
  • Polysaccharides
  • Receptors, Immunologic
  • Receptors, Lipoprotein
  • Receptors, Scavenger
  • Recombinant Proteins
  • Scarb1 protein, mouse
  • Scavenger Receptors, Class A
  • Scavenger Receptors, Class B
  • acetyl-LDL
  • Interleukin-4
  • fucoidan